Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg
2021 · Neuropharmacology · 33 citations
https://doi.org/10.1016/j.neuropharm.2021.108553
A
Andrew J. Roebuck
Yukon University(CA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
331
Citations
11
h-index
14
i10-index
Andrew J. Roebuck is an academic researcher from Yukon University. The author has contributed to research in topics: Cannabis and Cannabinoid Research & Neuroscience and Neuropharmacology Research & Memory and Neural Mechanisms. The author has an h-index of 11, co-authored 19 publications.
ORCID: 0000-0002-3008-8387Papers by this author
worksAntipsychotic potential of the type 1 cannabinoid receptor positive allosteric modulator GAT211: preclinical in vitro and in vivo studies
2021 · Psychopharmacology · 11 citations
https://doi.org/10.1007/s00213-020-05755-x
The type 1 cannabinoid receptor positive allosteric modulators GAT591 and GAT593 reduce spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg
2022 · IBRO Neuroscience Reports · 10 citations
https://doi.org/10.1016/j.ibneur.2022.01.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat